C

Center for Beta Cell Therapy in Diabetes (Non-profit association)

Juvenile Diabetes Research Foundation Center for Beta Cell Therapy in Diabetes VZW
BE 0872.566.468 Active ●Avenue du Laerbeek 103, 1090 Jette

Center for Beta Cell Therapy in Diabetes is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0872.566.468. It was founded on 17-03-2005. Its registered office is in Jette. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 2 624 530 and a loss of € 219 285. These accounts report 0.1 full-time equivalents. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.

Information last updated on 23-10-2026.

Company information

Status
Active
Enterprise number
BE 0872.566.468
VAT registered
No
Founded
17-03-2005
Latest accounts
2025
Employees
0.1 FTE
Region
Brussels-Capital
Establishments
1
Filing record
On time 4 of 4 years
Peppol e-invoicing
Registered
Registered office
Avenue du Laerbeek 103, 1090 Jette
Main activity
Scientific research and development
NACE activities
72109 Recherche-développement en autres sciences physiques et naturelles

Key figures of Center for Beta Cell Therapy in Diabetes

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -219 285-71 %€ -128 261-629 %€ -17 601+97 %€ -520 242
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 2 624 530-8 %€ 2 843 815-4 %€ 2 972 076-1 %€ 2 989 677
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 3 160 827-5 %€ 3 318 008+2 %€ 3 249 7940 %€ 3 258 961
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ -184 400-98 %€ -93 338+53 %€ -199 826+3 %€ -205 870
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
0.10 %0.1-50 %0.20 %0.2

Financial estimate

Financial health grade A, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
5 mandates on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity in Jette.

CompanyTown
EURIMMAUX 1090 Jette
iSHOP 1090 Jette
STRATELYON GROUP 1090 Jette
LabOmics 1090 Jette
STRATELYON BELGIUM 1090 Jette
Precirix 1090 Jette
HOEK BIOPROCESS ENGINEERING 1090 Jette
ClinOps Buddy 1090 Jette
Looking for more information about Center for Beta Cell Therapy in Diabetes?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is Center for Beta Cell Therapy in Diabetes still active? Yes. The Crossroads Bank for Enterprises lists Center for Beta Cell Therapy in Diabetes as active.

What is the VAT number of Center for Beta Cell Therapy in Diabetes? Center for Beta Cell Therapy in Diabetes is not registered for VAT. Its enterprise number is 0872.566.468.

When was Center for Beta Cell Therapy in Diabetes founded? Center for Beta Cell Therapy in Diabetes was founded on 17-03-2005.

What is the address of Center for Beta Cell Therapy in Diabetes? The current registered office of Center for Beta Cell Therapy in Diabetes is Avenue du Laerbeek 103, 1090 Jette.

When did Center for Beta Cell Therapy in Diabetes last file annual accounts? The latest annual accounts of Center for Beta Cell Therapy in Diabetes were filed on 24-07-2026.

Does Center for Beta Cell Therapy in Diabetes file its annual accounts on time? Yes. Center for Beta Cell Therapy in Diabetes filed its annual accounts within the legal deadline for each of its last 4 financial years.

How many employees does Center for Beta Cell Therapy in Diabetes have? Center for Beta Cell Therapy in Diabetes employs 0.1 full-time equivalents according to its most recent annual accounts.

Is Center for Beta Cell Therapy in Diabetes financially healthy? Addrly gives Center for Beta Cell Therapy in Diabetes a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is Center for Beta Cell Therapy in Diabetes profitable? The annual accounts of Center for Beta Cell Therapy in Diabetes for 2025 show a loss of € 219 285.

What is the equity of Center for Beta Cell Therapy in Diabetes? The equity of Center for Beta Cell Therapy in Diabetes was € 2 624 530 at the close of the 2025 financial year.

Who are the directors of Center for Beta Cell Therapy in Diabetes? The annual accounts of Center for Beta Cell Therapy in Diabetes record 5 mandates. The names, roles and dates are visible with a free account.

Can Center for Beta Cell Therapy in Diabetes receive Peppol e-invoices? Yes. Center for Beta Cell Therapy in Diabetes is registered on the Peppol network and can receive structured electronic invoices.

What does Center for Beta Cell Therapy in Diabetes do? The main activity of Center for Beta Cell Therapy in Diabetes is: Scientific research and development.

Sources

How Addrly builds and refreshes this data